Optimizing Therapeutics in the Management of Patients With Multiple Sclerosis: A Review of Drug Efficacy, Dosing, and Mechanisms of Action

Biologics: Targets and Therapy - New Zealand
doi 10.2147/btt.s53007
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

The New Era of Multiple Sclerosis Therapeutics

Neurotherapeutics
NeurologyPharmacology
2012English

The Use of Flow Cytometry to Assess a Novel Drug Efficacy in Multiple Sclerosis

Metabolic Brain Disease
BiochemistryMolecular NeuroscienceNeurologyCellular
2014English

Alemtuzumab: A Review of Efficacy and Risks in the Treatment of Relapsing Remitting Multiple Sclerosis

Therapeutics and Clinical Risk Management
2017English

The Present Efficacy of Multiple Sclerosis Therapeutics: Is the New 66% Just the Old 33%?

Neurology
Neurology
2009English

Editorial: Multiple Sclerosis: Pathogenesis and Therapeutics

Medicinal Chemistry
Drug Discovery
2018English

Comparative Efficacy of Alemtuzumab And established Treatment in the Management Of multiple Sclerosis

Neuropsychiatric Disease and Treatment
2015English

The Safety and Efficacy of Arbaclofen Extended Release Tablets in the Treatment of Spasticity in Patients With Multiple Sclerosis

Archives of Physical Medicine and Rehabilitation
Physical TherapySports TherapyRehabilitationSports Science
2016English

Therapeutic Efficacy of Interferon Β-1b in Japanese Patients With Optic-Spinal Multiple Sclerosis

Tohoku Journal of Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
2011English

Antiepileptic Drug Mechanisms of Action

Epilepsia
Neurology
1993English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy